These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2435266)

  • 1. [Antiallergic effect of MY-5116 and its major metabolite, MY-1250].
    Kohno SW; Ohata K
    Arerugi; 1986 Nov; 35(11):1105-12. PubMed ID: 2435266
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic agent, on the release of mediators from guinea pig lung fragments.
    Takahashi K; Yamada N; Endoh K; Yasumura K
    Arerugi; 1986 Sep; 35(9):982-7. PubMed ID: 2432858
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic drug, on histamine release from monkey lung fragments].
    Takahashi K; Shono T
    Arerugi; 1986 Sep; 35(9):975-81. PubMed ID: 2432857
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of action of MY-1250, an active metabolite of Repirinast, in inhibiting histamine release from rat mast cells.
    Takei M; Endo K; Takahashi K
    Br J Pharmacol; 1992 Mar; 105(3):587-90. PubMed ID: 1378339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect on the release of mediators from rat peritoneal exudate cells and the antagonistic effect against mediators of MY-5116 and other anti-allergic agents].
    Yamada N; Takahashi K; Endoh K; Arai Y
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):229-37. PubMed ID: 2431983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of chemical mediator release from human leukocytes and lung in vitro by a novel antiallergic agent, KB-2413.
    Nishimura N; Ito K; Tomioka H; Yoshida S
    Immunopharmacol Immunotoxicol; 1987; 9(4):511-21. PubMed ID: 2449488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a major metabolite of the antiallergic drug repirinast on phosphodiesterase and adenylate cyclase activities.
    Yamada N; Arai Y; Funayama K; Kadowaki S; Takahashi K; Umezu K
    Arzneimittelforschung; 1995 Jan; 45(1):33-5. PubMed ID: 7534459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic regulation of antigen-induced mediator release from canine lung.
    Krell RD; Chakrin LW
    Int Arch Allergy Appl Immunol; 1978; 56(1):39-47. PubMed ID: 73521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of MY-1250 on histamine release from rat peritoneal mast cells and guinea pig lung fragments: the elucidation of the mechanism.
    Kamei C; Mio M; Izushi K; Yoshii N; Fujisawa K; Tasaka K
    Immunopharmacol Immunotoxicol; 1991; 13(3):341-56. PubMed ID: 1719061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiallergic effects of terfenadine on immediate type hypersensitivity reactions.
    Akagi M; Mio M; Miyoshi K; Tasaka K
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):257-79. PubMed ID: 2449487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiallergic effect of trimetoquinol analogs on actively sensitized guinea pig lung tissue, in vitro.
    Mukhopadhyay A; Miller DD; Feller DR
    Biochem Pharmacol; 1986 Sep; 35(17):2977-9. PubMed ID: 2427089
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of aspirin and indomethacin on the immunological release of histamine and slow reacting substance of anaphylaxis (SRS-A) from guinea-pig lung tissues (author's transl)].
    Kitamura S; Ishihara Y; Izumi T; Kosaka K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 May; 18(5):317-21. PubMed ID: 6157854
    [No Abstract]   [Full Text] [Related]  

  • 13. [Release of histamine and slow reacting substance of anaphylaxis (SRS-A) from the sensitized guinea-pig lungs. 3. Effects of prostaglandin E2 and F2-alpha].
    Kitamura S; Ishihara Y; Sasaki K; Shimizu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1976 Nov; 14(11):656-62. PubMed ID: 64636
    [No Abstract]   [Full Text] [Related]  

  • 14. [Loratadine inhibits mediator liberation from a suspension of human pulmonary mast cells].
    Peters SP
    Allerg Immunol (Paris); 1991 Mar; 23(3):109. PubMed ID: 1712595
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological properties of BL-5255Z, an antiallergy compound that blocks SRS activity.
    Gillespie E; Dungan KW
    Monogr Allergy; 1983; 18():211-9. PubMed ID: 6196627
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K; Akagi M; Izushi K; Mio M
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic drug, on histamine release from rat peritoneal exudate cells and the degranulation of mesenteric mast cells].
    Takahashi K; Shono T; Arai Y
    Arerugi; 1986 Oct; 35(10):1028-36. PubMed ID: 2434065
    [No Abstract]   [Full Text] [Related]  

  • 18. [Release of histamine and slow reacting substance of anaphylaxis (SRS-A) from the sensitized guinea-pig lungs. 1. Experimental studies].
    Kitamura S; Ishihara Y; Shimizu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1976 Nov; 14(11):645-9. PubMed ID: 64634
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
    Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
    Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis].
    Terasawa M; Imayoshi T; Goto K
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):93-101. PubMed ID: 6194083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.